These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1167 related articles for article (PubMed ID: 33839757)

  • 1. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
    Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
    Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
    Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
    Han J; Puri RK
    J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma.
    Lai J; Lin X; Zheng H; Xie B; Fu D
    BMC Cancer; 2023 Jun; 23(1):525. PubMed ID: 37291533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma.
    Chai Y; Wang C; Liu W; Fan Y; Zhang Y
    J Neurooncol; 2019 Sep; 144(2):293-301. PubMed ID: 31236818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients.
    Liu M; Zhou R; Zou W; Yang Z; Li Q; Chen Z; Jiang L; Zhang J
    Stem Cell Res Ther; 2023 Sep; 14(1):238. PubMed ID: 37674202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients.
    Chen D; Liu J; Zang L; Xiao T; Zhang X; Li Z; Zhu H; Gao W; Yu X
    Int J Biol Sci; 2022; 18(1):360-373. PubMed ID: 34975338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.
    Liu B; Liu J; Liao Y; Jin C; Zhang Z; Zhao J; Liu K; Huang H; Cao H; Cheng Q
    Med Sci Monit; 2019 May; 25():3624-3635. PubMed ID: 31094363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
    Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells.
    Drachsler M; Kleber S; Mateos A; Volk K; Mohr N; Chen S; Cirovic B; Tüttenberg J; Gieffers C; Sykora J; Wirtz CR; Mueller W; Synowitz M; Martin-Villalba A
    Cell Death Dis; 2016 Apr; 7(4):e2209. PubMed ID: 27124583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype.
    Yan W; Liu Y; Yang P; Wang Z; You Y; Jiang T
    Oncotarget; 2015 May; 6(13):11676-82. PubMed ID: 25869098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
    Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
    Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma.
    Sun Z; Zhao Y; Wei Y; Ding X; Tan C; Wang C
    Front Immunol; 2022; 13():939523. PubMed ID: 36091049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma.
    Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D
    Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial neural network identified a 20-gene panel in predicting immunotherapy response and survival benefits after anti-PD1/PD-L1 treatment in glioblastoma patients.
    Wang Y; Wang Z; Guo X; Cao Y; Xing H; Wang Y; Xing B; Wang Y; Yao Y; Ma W
    Cancer Med; 2024 May; 13(9):e7218. PubMed ID: 38733169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPPED2 is downregulated in glioblastoma, and its restoration inhibits proliferation and increases the sensitivity to temozolomide of glioblastoma cells.
    Pellecchia S; De Martino M; Esposito F; Quintavalle C; Fusco A; Pallante P
    Cell Cycle; 2021 Apr; 20(7):716-729. PubMed ID: 33734003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.